Peptide
Vesilute
SaveA Khavinson bioregulator dipeptide (Lys-Glu) claimed to normalize urinary and immune system function.
Quick verdict
Part of the Khavinson peptide bioregulator series. Minimal evidence outside Russian-language publications.
Evidence score
12/ 100
A rough internal score reflecting quantity, quality, and consistency of human evidence. Not a clinical recommendation.
What the research shows
Russian-language publications from the Khavinson group only. No independent replication or international peer review.
Benefits
- Claimed immune and urinary system support in Russian literature
- Oral bioregulator format
Dosage notes
Russian protocols: 5–10 mg/day orally for 10–30 day courses.
Side effects
- Not well characterized
Who should be cautious
Not approved outside Russia. Product authenticity cannot be verified from online sources.
What this page cannot tell you
All data from a single research group. Claims are unverified internationally.
Leaderboard scores
- Immunity12
Write a review
Sign in to write a review.